Product Information
AMLODIPINE-VALSARTAN 5-320 MG is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.3511 per EA under NDC 62332020790. Its NADAC has been published 471 times since Sep 27, 2017.
FDA first approved this application on Apr 3, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 320 mg/1; mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332020790
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202713FDA Approved
4/3/2015
TE Code
AB
On Market Since
12/1/2016
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 5-320 MG has been published 471 times since Sep 27, 2017, and over the history we have for it it has declined 41.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3511 per EA |
|---|---|
| All-time high | $0.6544 (Nov 10, 2021) |
| All-time low | $0.3511 (Sep 23, 2026) |
| 52-week high | $0.5476 |
| 52-week low | $0.3511 |
| Median price | $0.5520 |
| Average price | $0.5433 |
| Largest weekly change | +59.9% (Jun 19, 2024) |
| Weeks tracked | 471 |
| Tracking since | Sep 27, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine and Valsartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 5-320 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-320 MG, manufactured by Alembic Pharmaceuticals Inc., is $0.3511 per EA (NDC 62332020790), effective Sep 30, 2026.
How has the price of AMLODIPINE-VALSARTAN 5-320 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-320 MG has declined 41.0%. It has been tracked across 471 weekly CMS publications since Sep 27, 2017.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-320 MG?
Since Sep 27, 2017, the NADAC for AMLODIPINE-VALSARTAN 5-320 MG has ranged from a low of $0.3511 (Sep 23, 2026) to a high of $0.6544 (Nov 10, 2021), with a median of $0.5520 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-320 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-VALSARTAN 5-320 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-VALSARTAN 5-320 MG?
AMLODIPINE-VALSARTAN 5-320 MG (NDC 62332020790) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.